The Ebola Equation: How US Aid Cuts, a Rare Virus Strain, and Armed Conflict Converged in Eastern Congo

On April 24, 2026, a health worker in the Mongbwalu health zone of Ituri Province, northeastern Democratic Republic of Congo, reported symptoms consistent with Ebola [1]. Three weeks passed before laboratory analysis confirmed the cause: Bundibugyo virus, a rare Ebola species first identified in Uganda in 2007 [2]. By then, the virus had already been circulating undetected for an estimated six to eight weeks [3]. By the time the DRC Ministry of Health formally declared the outbreak on May 15, suspected cases and unexplained deaths had spread across nine health zones near the Ugandan border [2].

As of May 19, the toll stood at 516 suspected cases, 33 confirmed cases, and 131 deaths in the DRC, with two confirmed cases — including one fatality — in Uganda's capital, Kampala [4][5]. The World Health Organization declared a Public Health Emergency of International Concern (PHEIC) on May 17, citing the "scale and speed" of the outbreak and the absence of any licensed vaccine or therapeutic treatment for the Bundibugyo strain [6].

The outbreak has reignited a fierce debate: Did the Trump administration's dismantling of USAID and deep cuts to global health funding leave the DRC unable to catch Ebola before it spread? Or would this outbreak — fueled by armed conflict, displacement, and a virus with no countermeasures — have overwhelmed even a fully funded response?

The Funding Collapse

The numbers tell a stark story. Total US foreign aid to the DRC fell from nearly $1.2 billion in fiscal year 2024 to $715 million in FY2025, then collapsed to just $67 million in the first quarter of FY2026 [7][8]. The Department of Health and Human Services sent nearly $33 million to the DRC in FY2024; that figure fell below $10 million in FY2025 [8]. US humanitarian aid to the country dropped by approximately 80% during the Trump administration [3].

Source: PolitiFact / USAID

Data as of May 19, 2026CSV

The cuts were part of a broader retrenchment. The administration's FY2026 budget proposed $493.2 million for Global Health Security programs — a $500 million reduction from the FY2025 baseline of $993 million [9]. USAID, which had been the primary vehicle for US epidemic preparedness work overseas, was formally dissolved in July 2025, with remaining global health functions transferred to the State Department's Bureau of Global Health Security and Diplomacy [9].

The staffing losses were severe. USAID's international outbreak response team shrank from approximately 50 personnel to six [9]. The International Rescue Committee, a major USAID contractor, reduced its programming in the outbreak's epicenter from five health areas to two in Ituri Province after US government funding ended in March 2025 [10]. The activities lost included disease surveillance, communicable disease treatment, water and sanitation infrastructure, and infection prevention systems [10].

A Virus With No Countermeasures

The Bundibugyo strain presents a challenge that no amount of funding can fully solve in the short term. The licensed Ebola vaccine Ervebo and monoclonal antibody treatments like Inmazeb were developed against the Zaire species, which causes the vast majority of outbreaks [11]. Bundibugyo's genetic makeup differs enough that these tools do not provide reliable protection [11].

This distinguishes the current outbreak from both the 2018–2020 North Kivu epidemic (3,481 cases, 2,299 deaths from the Zaire strain) and the 2014–2016 West Africa crisis (28,616 cases from the Zaire strain) [12]. During the Kivu outbreak, a vaccination campaign reached more than 300,000 people and was central to bringing it under control [11]. No equivalent tool exists for Bundibugyo, which has a historical case fatality rate of 30% to 40% [2].

Source: WHO / CDC

Data as of May 19, 2026CSV

The Bundibugyo strain also complicated initial detection. Standard rapid diagnostic tests used in the field are designed for Zaire Ebola and can miss Bundibugyo infections, requiring samples to be sent to larger reference laboratories [3]. In this case, samples from Ituri Province were shipped to Kinshasa — reportedly at incorrect temperatures and in insufficient quantities, further delaying confirmation [1].

What Surveillance Was Lost

Before the cuts, USAID personnel, CDC teams, humanitarian organizations, and local health workers formed a layered surveillance network across the DRC, with particular density in the conflict-affected eastern provinces [3]. This system included field monitoring, sample transportation logistics, laboratory coordination, and community alert networks [9].

Former USAID Acting Assistant Administrator for Global Health Nicholas Enrich told NBC News: "What we've lost is speed, which is the most important thing in an outbreak like this" [1]. He noted that USAID programs previously enabled laboratory detection, distributed protective gear, and deployed community health workers to remote areas.

Former CDC medical officer Dr. Daniel Bausch described what happened to trained community health workers after funding dried up: "Now they're driving a taxi in Kinshasa or selling fruit somewhere" [1]. These workers had served as an informal early-warning system, often able to reach communities inaccessible to government officials in conflict zones.

The IRC's country director, Heather Reoch Kerr, stated directly: "Funding cuts have left the region dangerously exposed. The sharp rise in reported cases over the last few days reflects the reality that surveillance systems are now catching up with transmission that has likely been occurring for some time" [10].

CDC Ebola response manager Satish Pillai noted that the agency received notification of the first confirmed case only one day before the official outbreak announcement — a compressed timeline compared to past outbreaks, when earlier informal notice was typical [3].

The Administration's Response

The State Department has pushed back against the narrative linking aid cuts to the outbreak. Spokesman Tommy Pigott stated: "It is false to claim that the USAID reform has negatively impacted our ability to respond to Ebola" [1][3].

On May 19, the State Department announced it had mobilized $23 million in bilateral foreign assistance to "bolster each country's own response, supporting surveillance, laboratory capacity, risk communication, safe burials, entry and exit screening, and clinical case management" [13]. The department also announced funding for up to 50 clinics for emergency screening and isolation [1].

In 2025, when the Department of Government Efficiency led by Elon Musk reviewed USAID spending, Musk acknowledged that US support for Ebola prevention efforts had been "accidentally" canceled [8]. He stated the funding had been "restored" with "no interruption," though public health experts disputed that characterization, citing continued inadequate resources for testing and screening programs [8].

The Conflict Factor

Eastern Congo's security environment would strain any outbreak response, regardless of funding levels. Armed groups including the Allied Democratic Forces and M23 operate in Ituri and surrounding provinces, limiting health worker access and disrupting contact tracing [5]. Population displacement linked to both conflict and mining activity creates conditions favorable to disease transmission [5].

Dr. David Heymann, professor at the London School of Hygiene and Tropical Medicine and a former CDC epidemiologist, argued that the core issue is lack of international coordination rather than insufficient funding [1]. This represents a minority but substantive view among epidemiologists — that the DRC's ongoing instability, combined with the absence of countermeasures against Bundibugyo, means the outbreak trajectory may not have been significantly different even with full US funding in place.

Jeremy Konyndyk, a former USAID official under the Obama administration, offered the opposing assessment: "I'm very, very worried. If I compare this to past outbreaks, this one has more momentum at time of detection than the huge West Africa outbreak in 2014 did" [3]. He added: "We are just in a much, much weaker position now to respond to a challenging Ebola outbreak like this one than we would have been even 18 to 24 months ago" [3].

The honest answer is that both factors — reduced aid and structural barriers — are operating simultaneously, and disentangling their relative contributions with precision is not possible at this stage of the outbreak.

Can Other Donors Fill the Gap?

The short answer appears to be no — at least not quickly or completely. European donors including Germany, France, the Netherlands, and Sweden face competing demands from the war in Ukraine, increased defense spending, climate commitments, and upcoming replenishments for the Global Fund and Gavi [14]. The DRC was identified by the Center for Global Development as among 26 countries most vulnerable to US global health aid cuts [14].

Gavi, the global vaccine alliance, held a replenishment summit that secured pledges exceeding $9 billion toward an $11.9 billion target for 2026–2030 [15]. But Congress had appropriated $300 million for Gavi in both FY2025 and FY2026, and the Trump administration has not disbursed those funds [15]. The shortfall represents a genuine net reduction in total resources available, not merely a reallocation between donor-branded programs.

The DRC itself ranks seventh globally in its refugee-producing population, with over 1.1 million refugees, reflecting the scale of displacement and instability that any international response must contend with [16].

Source: UNHCR Population Data

Data as of Dec 31, 2025CSV

The Legal Battle Over Appropriated Funds

The constitutional question of whether the executive branch can freeze congressionally appropriated foreign aid funds has been litigated but not definitively resolved.

In early 2025, District Court Judge Amir Ali barred the administration from impounding appropriated foreign aid and ordered payment of existing USAID contracts, ruling that the funding freeze "flouts multiple statutes whose constitutionality is not in question" [17]. A D.C. Circuit panel vacated that injunction in a 2-1 ruling, finding that only the Government Accountability Office — not affected individuals — could sue under the 1974 Impoundment Control Act [17].

In September 2025, the Supreme Court granted the administration's emergency request to withhold billions in foreign aid, writing that "the government, at this early stage, has made a sufficient showing that the Impoundment Control Act precludes respondents' suit" — while noting this "should not be read as a final determination on the merits" [17].

Congress has pushed back through the appropriations process. The FY2026 foreign aid bill includes explicit prohibitions on deviating from congressional global health funding levels [9]. Senator Chris Murphy led a letter demanding the administration reverse what he called the "illegal impoundment" of $3.2 billion in FY2025 funds that were being redirected to cover USAID closure costs [18].

The Recovery Lag

Even if US aid were restored to prior levels tomorrow, the surveillance and response infrastructure that took years to build would not snap back into place overnight. Rebuilding community health worker networks, re-establishing laboratory supply chains, and re-staffing outbreak response teams requires recruitment, training, and the restoration of community trust — a process that epidemiologists familiar with past DRC outbreaks estimate would take months, not weeks [1][10].

An anonymous former USAID official told NBC News: "The fact that this has been circulating for this long indicates that the system has degraded" [1]. The implication is that the window for early containment — the period when Ebola outbreaks are most controllable — may have already closed for this outbreak.

At Bwera Hospital in Kasese, Uganda, near the DRC border, Dr. Herbert Luswata reported shortages of N95 masks, disposable aprons, and gloves, along with insufficient infection prevention staff [1]. "We are really very scared. We are not safe at all," he said [1].

What Comes Next

The 2026 Ituri outbreak sits at the intersection of three compounding factors: a virus strain with no vaccine, a conflict zone with limited health infrastructure, and a surveillance system weakened by the largest reduction in US global health funding in recent memory. Each factor alone would present a serious challenge. Together, they have produced what the WHO classified as an international emergency within days of the outbreak's confirmation.

The debate over causation — how much of this crisis traces to policy decisions in Washington versus conditions on the ground in eastern Congo — will continue as case counts rise. What is less debatable is the arithmetic: the DRC received $1.2 billion in US aid in FY2024 and $67 million in the most recent quarter. The International Rescue Committee went from operating in five health areas to two. USAID's outbreak response team went from 50 people to six. The Bundibugyo virus, indifferent to these policy choices, circulated undetected for weeks in the gap that was left behind.